The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluation of oral S-1 as a first-line chemotherapy for metastatic HER2-negative breast cancer: An analysis of two randomized phase III studies (SELECT BC-CONFIRM and SELECT BC).
 
Reiki Nishimura
Honoraria - Chugai Pharma; Novartis; Pfizer
 
Hirofumi Mukai
No Relationships to Disclose
 
Yukari Uemura
No Relationships to Disclose
 
Hiromitsu Akabane
No Relationships to Disclose
 
Youngjin Park
No Relationships to Disclose
 
Masato Takahashi
Speakers' Bureau - AstraZeneca Japan; Kyowa Hakko Kirin; Lilly; Novartis; Pfizer; Taiho Pharmaceutical
 
Yoshiaki Sagara
Honoraria - AstraZeneca Japan; Chugai Pharma; Eisai; Novartis; Pfizer; Taiho Pharmaceutical; Takeda
 
Tsutomu Takashima
Honoraria - Chugai Pharma; Taiho Pharmaceutical
 
Tomomi Fujisawa
Speakers' Bureau - Chugai Pharma; Daiichi Sankyo; Novartis; Taiho Pharmaceutical
 
Yasuo Hozumi
No Relationships to Disclose
 
Takuya Kawahara
No Relationships to Disclose
 
Takanori Watanabe
No Relationships to Disclose